Because many EDCs are capable of affecting other nuclear receptors, we tested BPAP effects upon modulating the levels of several endogenous NRs (ER, glucocorticoid receptor, GR, and progesterone receptor, PR) in breast cancer cells (Figure 3I–3K). Here, PGR is linked to breast cancer.